Difference between revisions of "About-cancer/treatment/drugs/endometrial"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
| + | <languages/> | ||
| + | <translate> | ||
== Drugs Approved for Endometrial Cancer == | == Drugs Approved for Endometrial Cancer == | ||
| Line 14: | Line 16: | ||
Pembrolizumab | Pembrolizumab | ||
| + | </translate> | ||
Revision as of 17:26, 28 October 2019
Drugs Approved for Endometrial Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for endometrial cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in endometrial cancer that are not listed here.
Drugs Approved for Endometrial Cancer
Keytruda (Pembrolizumab)
Lenvatinib Mesylate
Lenvima (Lenvatinib Mesylate)
Megestrol Acetate
Pembrolizumab
